Walter, Roland B. http://orcid.org/0000-0002-9268-3341
Article History
Received: 20 October 2023
Revised: 24 October 2023
Accepted: 7 November 2023
First Online: 16 November 2023
Competing interests
: RBW received laboratory research grants and/or clinical trial support from Aptevo, Celgene, ImmunoGen, Janssen, Jazz, Kite, Kura, and Pfizer; has ownership interests in Amphivena; and is (or has been) a consultant to Abbvie, Adicet, Amphivena, BerGenBio, Bristol Myers Squibb, GlaxoSmithKline, ImmunoGen, Kura, and Orum.